NEW YORK (GenomeWeb) – Molecular diagnostics Firm Xagenic today announced that it has raised C$15 million ($11.8 million) in new financing that it hopes will accelerate its efforts to develop and commercialize its point-of-care diagnostic platform.

Headquartered in Toronto, Xagenic has been developing a platform it calls the Xagenic X1 based on a core technology that was originally developed by researchers at the University of Toronto.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.